ArticleCommunications chemistry2025
Tailoring aggregation-induced emission in luminescent solar concentrators through controlled polymerization.
Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Luminescent solar concentrators (LSCs) hold great potential as versatile energy conversion systems for diverse applications. Here, we explore the covalent incorporation of aggregation-induced emission (AIE) luminogens into polymeric backbones for LSCs. Copolymers based on methyl-methacrylate and an AIE-active monomer (tetraphenyl ethylene methacrylate - TPEMA) are synthesized using free radical (FR) and reversible addition-fragmentation chain transfer (RAFT) polymerizations. By integrating TPEMA into the polymer structure, we exploit its unique emission properties when the AIEgens are in close proximity. RAFT polymerization affords copolymers with narrower molecular weight distribution, improved thermal stability, higher glass transition temperature, and optical properties that scale positively with TPEMA content, outperforming FR analogues. RAFT-based LSC devices exhibit more consistent performance, underscoring the importance of controlled polymerization on AIEgen response and device behavior. This study demonstrates an effective strategy to enhance LSC response through synthetic control of the macromolecular network and strategic incorporation of AIEgens into luminescent polymer matrices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.